214 related articles for article (PubMed ID: 20003385)
1. The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray.
Xiao L; Wang YC; Li WS; Du Y
J Exp Clin Cancer Res; 2009 Dec; 28(1):152. PubMed ID: 20003385
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
3. Downregulated parafibromin expression is a promising marker for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Virchows Arch; 2008 Feb; 452(2):147-55. PubMed ID: 18080135
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
5. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer.
An JY; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
Int J Cancer; 2010 Jun; 126(12):2904-13. PubMed ID: 19739122
[TBL] [Abstract][Full Text] [Related]
8. MUC6 down-regulation correlates with gastric carcinoma progression and a poor prognosis: an immunohistochemical study with tissue microarrays.
Zheng H; Takahashi H; Nakajima T; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Dec; 132(12):817-23. PubMed ID: 16807756
[TBL] [Abstract][Full Text] [Related]
9. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
Alabdullah ML; Ahmad DA; Moseley P; Madhusudan S; Chan S; Rakha E
J Obstet Gynaecol; 2019 May; 39(4):522-528. PubMed ID: 30712414
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
11. Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.
Xu XY; Gou WF; Yang X; Wang GL; Takahashi H; Yu M; Mao XY; Takano Y; Zheng HC
Tumour Biol; 2012 Dec; 33(6):1845-54. PubMed ID: 22948776
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of mammalian target of rapamycin/P70 ribosomal protein S6 kinase signaling pathway in human colorectal carcinoma tissue.
Lu Q; Wang J; Yu G; Guo T; Hu C; Ren P
Oncol Lett; 2015 Jul; 10(1):277-282. PubMed ID: 26171014
[TBL] [Abstract][Full Text] [Related]
13. Morphoproteomics demonstrates activation of mammalian target of rapamycin pathway in papillary thyroid carcinomas with nuclear translocation of MTOR in aggressive histological variants.
Liu J; Brown RE
Mod Pathol; 2011 Dec; 24(12):1553-9. PubMed ID: 21822208
[TBL] [Abstract][Full Text] [Related]
14. mTOR/p70S6K signal transduction pathway contributes to osteosarcoma progression and patients' prognosis.
Zhou Q; Deng Z; Zhu Y; Long H; Zhang S; Zhao J
Med Oncol; 2010 Dec; 27(4):1239-45. PubMed ID: 19936974
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy.
Pantuck AJ; Seligson DB; Klatte T; Yu H; Leppert JT; Moore L; O'Toole T; Gibbons J; Belldegrun AS; Figlin RA
Cancer; 2007 Jun; 109(11):2257-67. PubMed ID: 17440983
[TBL] [Abstract][Full Text] [Related]
16. Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.
Johnson SM; Gulhati P; Rampy BA; Han Y; Rychahou PG; Doan HQ; Weiss HL; Evers BM
J Am Coll Surg; 2010 May; 210(5):767-76, 776-8. PubMed ID: 20421047
[TBL] [Abstract][Full Text] [Related]
17. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
18. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
19. Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling.
Dou N; Yu S; Ye X; Yang D; Li Y; Gao Y
Oncotarget; 2016 Dec; 7(52):86161-86173. PubMed ID: 27863387
[TBL] [Abstract][Full Text] [Related]
20. [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma].
Li JF; Li GD; Gu L; Liu WP; Li FY; Liao DY; Ma ZG
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):649-53. PubMed ID: 19176054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
